Replies to post #388888 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks for the numbers..
Sleven,

[couldbebetter]

Relatively speaking these numbers look good!
As always Raf, very much appreciated.

[Bolio98]

Wow, glad to see the fake guys took it on the chin.

[Meowza]

So few CVD patients getting V treatment.

Worth it, as long as no one gets rich off of "fish oil".

[rafunrafun]

Scripts for week ending September 16, 2022

Drug Industry TRx: +5.5% w/w; +7.1% y/y

Vascepa
TRx 64,464; +4.8% (+2,948) w/w; -21.5% y/y
NRx 29,796; +10.2% (+2,752) w/w; -19.7% y/y
Ref 34,668; +0.6% (+196) w/w; -22.9% y/y

Lovaza (Fake & Brand)
TRx 65,492; +9.1% (+5,450) w/w; +1.9% y/y
NRx 32,289; +14.3% (+4,046) w/w; +2.8% y/y
Ref 33,203; +4.4% (+1,404) w/w; +1.0% y/y

Fake Vascepa
TRx 40,043; +6.8% (+2,566) w/w; As % of total V: 38.3%
NRx 19,465; +12.9% (+2,225) w/w; As % of total V: 39.5%
Ref 20,578; +1.7% (+341) w/w; As % of total V: 37.2%

Fake Vascepa by Manufacturer
Hikma - TRx 14,367; (+917) w/w; Generic share 35.9%; Total V share 13.7%
Reddy - TRx 18,124; (+934) w/w; Generic share 45.3%; Total V share 17.3%
Apotex - TRx 7,552; (+715) w/w; Generic share 18.9%; Total V share 7.2%

Vascepa + Fake Vascepa
TRx 104,507; +5.6% (+5,514) w/w; +3.1% y/y
NRx 49,261; +11.2% (+4,977) w/w; +2.7% y/y
Ref 55,246; +1.0% (+537) w/w; +3.5% y/y